Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

Q&A: NIAID’s Jeanne Marrazzo speaks on bird flu, mpox, and succeeding Anthony Fauci

A year ago last week, Jeanne Marrazzo stepped into a very big pair of shoes. Marrazzo became the first new director of the National Institute

October 1, 2024

Rare Syndrome After COVID Vaccines Described

People who experienced rare long-term adverse events after COVID-19 vaccination often had neurologic symptoms, survey data showed. Among 241 people who self-reported a post-vaccination syndrome

December 2, 2023

Shasqi using click chemistry to target cancer

Shasqi, Inc., whose mission is to revolutionize cancer treatment with click chemistry, has entered into a research collaboration with Johnson & Johnson Enterprise Innovation Inc.

June 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.